re: Ann: Mater Hospital ethics approval for H...
I thought it was quite an interesting and exciting ann, seems to off gone un-noticed by the market. To get approvals from Ethics Committees arn't easy things to do.
Mater Hospital ethics approval for HealthLinx OvPlex study Australia’s largest birthing hospital in quest for highly accurate ovarian cancer diagnostic 23 November 2009, Melbourne: The Ethics Committee at Queensland’s Mater Hospital has approved participation in the HealthLinx Limited (ASX:HTX) second and larger clinical study of ovarian cancer diagnostic OvPlex™. This study has been designed to rigorously establish the diagnostic efficiency of OvPlex in symptomatic women and statistically compare its performance to CA125. The outcome of this study will result in HealthLinx having developed a best in class early stage ovarian cancer diagnostic that will crystallise commercial returns for the company.
HTX Price at posting:
8.9¢ Sentiment: Buy Disclosure: Held
